XML 440 R160.htm IDEA: XBRL DOCUMENT
v3.23.1

Subsequent Events (Details) - USD ($) $ in Thousands | Apr. 24, 2023 | Mar. 22, 2023 | Mar. 01, 2023 | Feb. 21, 2023 | Dec. 31, 2022 | Jul. 27, 2022 | Dec. 31, 2021
--- | --- | --- | --- | --- | --- | --- | ---
Subsequent Events [Line Items] |  |  |  |  |  |  |
Short-term note from associate |  |  |  |  | $ 0 |  | $ 15,120
Convertible note receivable | Gelesis |  |  |  |  |  |  |
Subsequent Events [Line Items] |  |  |  |  |  |  |
Short-term note from associate |  |  |  |  |  | $ 15,000 |
Current receivable due from associates, interest rate |  |  |  |  |  | 15.00% |
Issuance of convertible note receivable | Convertible note receivable | Gelesis |  |  |  |  |  |  |
Subsequent Events [Line Items] |  |  |  |  |  |  |
Short-term note from associate |  |  |  | $ 5,000 |  |  |
Current receivable due from associates, interest rate |  |  |  | 12.00% |  |  |
Issuance of convertible notes | Vedanta |  |  |  |  |  |  |
Subsequent Events [Line Items] |  |  |  |  |  |  |
Proceeds from issue of convertible notes | $ 18,000 |  |  |  |  |  |
Issuance of convertible notes | Investor | Vedanta |  |  |  |  |  |  |
Subsequent Events [Line Items] |  |  |  |  |  |  |
Proceeds from issue of convertible notes |  |  | $ 88,500 |  |  |  |
Borrowings, interest rate |  |  | 9.00% |  |  |  |
Convertible note, percentage of equity price trigger |  |  | 80.00% |  |  |  |
Issuance of convertible notes | Borrowing From PureTech Health | Vedanta |  |  |  |  |  |  |
Subsequent Events [Line Items] |  |  |  |  |  |  |
Proceeds from issue of convertible notes | $ 5,000 |  |  |  |  |  |
Sale of royalty interest | Royalty Pharma |  |  |  |  |  |  |
Subsequent Events [Line Items] |  |  |  |  |  |  |
Sale of royalty interest, expected consideration |  | $ 100,000 |  |  |  |  |
Sale of royalty interest, contingent consideration (up to) |  | $ 400,000 |  |  |  |  |

X
- Definition The interest rate on borrowings. [Refer: Borrowings] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 7 -IssueDate 2022-03-24 -Paragraph 7 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_7&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_BorrowingsInterestRate
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The amount of current receivables due from associates. [Refer: Associates [member]] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2022-03-24 -Paragraph 78 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_b&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_CurrentReceivablesDueFromAssociates
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Current Receivable Due From Associates, Interest Rate + References No definition available. + Details
Name: | ptv_CurrentReceivableDueFromAssociatesInterestRate
Namespace Prefix: | ptv_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Debt Instrument, Convertible, Percentage Of Equity Price Trigger + References No definition available. + Details
Name: | ptv_DebtInstrumentConvertiblePercentageOfEquityPriceTrigger
Namespace Prefix: | ptv_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Proceeds from issue of convertible notes + References No definition available. + Details
Name: | ptv_ProceedsFromIssueOfConvertibleNotes
Namespace Prefix: | ptv_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Sale Of Royalty Interest, Consideration, Expected + References No definition available. + Details
Name: | ptv_SaleOfRoyaltyInterestConsiderationExpected
Namespace Prefix: | ptv_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Sale Of Royalty Interest, Contingent Consideration + References No definition available. + Details
Name: | ptv_SaleOfRoyaltyInterestContingentConsideration
Namespace Prefix: | ptv_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Subsequent Events + References No definition available. + Details
Name: | ptv_SubsequentEventsLineItems
Namespace Prefix: | ptv_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_ClassesOfFinancialAssetsAxis=ptv_ConvertibleNoteReceivableMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInAssociatesAxis=ptv_GelesisMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ptv_IssuanceOfConvertibleNoteReceivableMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ptv_IssuanceOfConvertibleNotesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=ptv_VedantaBiosciencesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=ptv_InvestorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=ptv_BorrowingFromPureTechHealthMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ptv_SaleOfRoyaltyInterestMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=ptv_RoyaltyPharmaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |